NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,393 | +13.7% | 2,792 | +12.7% | 0.04% | +15.6% |
| Q2 2023 | $250,055 | +0.2% | 2,478 | -8.7% | 0.03% | -5.9% |
| Q1 2023 | $249,596 | +15.6% | 2,713 | +14.0% | 0.03% | +9.7% |
| Q4 2022 | $215,823 | +15.4% | 2,379 | +7.5% | 0.03% | +29.2% |
| Q2 2022 | $187,000 | -8.8% | 2,212 | +1.7% | 0.02% | -17.2% |
| Q4 2020 | $205,000 | +29.7% | 2,174 | +32.3% | 0.03% | +7.4% |
| Q1 2019 | $158,000 | +2.6% | 1,643 | -8.7% | 0.03% | -15.6% |
| Q4 2018 | $154,000 | +3.4% | 1,799 | +3.9% | 0.03% | +28.0% |
| Q3 2018 | $149,000 | +13.7% | 1,731 | 0.0% | 0.02% | +4.2% |
| Q2 2018 | $131,000 | +10.1% | 1,731 | +17.4% | 0.02% | +9.1% |
| Q1 2018 | $119,000 | -4.0% | 1,474 | 0.0% | 0.02% | -4.3% |
| Q4 2017 | $124,000 | – | 1,474 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |